8-KThe WireRoutine
Reg FD Disclosure
Filed Apr 9, 2021 · 5y ago · Accession 0001193125-21-110829
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Tarsus Pharmaceuticals, Inc.
- Ticker
- TARS
- CIK
- 1819790
- Form type
- 8-K
- Filing date
- Apr 9, 2021
- Report date
- Apr 8, 2021
- Document
- d119854d8k.htm
- Size
- 14.6 MB